Science Snapshot: Fighting Depression with Magnetic Stimulation
Short video about the implementation of a procedure called TMS – used for treatment of drug-resistant depression – at the Champalimaud Centre for the Unknown.
Zebrafish “avatars” can help decide who should receive radiotherapy treatment
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients. This is a significant problem as patients may be unnecessarily subjected to potentially severe side effects. A new assay offers a promising solution with rapid, personalized radiotherapy compatibility testing, using zebrafish as avatars.
Champalimaud scientist awarded €2 million to investigate how the brain 'learns on its feet'
Megan Carey, the leader of the Neural Circuits and Behaviour lab at the Champalimaud Centre for the Unknown in Lisbon, Portugal, receives a Consolidator Grant from the European Research Council (ERC) to support her research for the next five years. It is the second five-year ERC grant awarded to Carey, following a €1.5 million Starting Grant in 2014.